Molina Healthcare, Inc. (NYSE:MOH) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET
Company Participants
Jeffrey Geyer - Head of Investor Relations
Joe Zubretsky - President, Chief Executive Officer
Mark Keim - Chief Financial Officer
Conference Call Participants
Josh Raskin - Nephron Research
A.J. Rice - UBS
Sarah James - Cantor Fitzgerald
Stephen Baxter - Wells Fargo
Justin Lake - Wolfe Research
Andrew Mok - Barclays
Adam Ron - Bank of America
Ryan Langston - TD Cowen
Michael Hall - Baird
Scott Fidel - Stephens
George Hill - Deutsche Bank
Operator
Good morning and welcome to Molina HealthCare's Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions]. Please note this event is being recorded.
I would now like to turn the conference over to Jeffrey Geyer, Vice President Investor Relations at Molina HealthCare. Please go ahead.
Jeffrey Geyer
Good morning and welcome to Molina HealthCare's third quarter 2024 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky and our CFO, Mark Keim. A press release announcing our third quarter 2024 earnings was distributed after the market closed yesterday and it's available on our Investor Relations website.
Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listened to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Thursday, October 24th, 2024, and have not been updated subsequent to the initial earnings call.
On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the third quarter 2024 earnings release.
During the call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2024 guidance, Medicaid redeterminations, expected Medicaid rate adjustments and updates, medical cost initiatives and our projected MCR, our recent RFP awards and pending RFP submissions, our acquisitions and M&A activity, revenue growth related to RFPs and M&A activity, our long-term growth strategy, our 2025 marketplace pricing, and our embedded earnings power and future earnings realization.
Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our foreign 10-K annual report filed with the SEC, as well as our risk factors listed in our form 10-Q and form 8-K filings with the SEC. After completion of our prepared remarks, we'll open the call to take your questions.